According to a new report published by Polaris Market Research, the endoscopy devices market size was valued at USD 60.94 billion in 2024. It is estimated to reach USD 87.41 billion by 2034, registering a CAGR of 3.68% from 2025 to 2034.
Endoscopy devices are adaptable tools that merge fiber optics and charge-coupled devices to provide illumination and visualization of otherwise unapproachable sites such as the lumen of vacant organs. An endoscope comprises a tip, an insertion tube, and a control section. Modern endoscopes are competent of offering high definition, high clarification images that can be enhanced to inspect the mucosa more comprehensively.
The most commonly used endoscopic instruments are gastroscopes and colonoscopes, which are used to examine the upper gastrointestinal tract and colon, respectively. Therapeutic endoscopes with large channel diameters, allowing the passage of complex and advanced accessories, are also available for advanced interventional procedures. Specialized endoscopes can be used to inspect the small bowel, biliary and pancreatic ductal systems, as well as extra-luminal anatomy.
The growing existence of detrimental illnesses is a prominent driver of the market as conditions such as cancer, gastrointestinal disorders, and cardiovascular illnesses growingly need early and precise diagnosis. A December 2024 WHO report propounded that noncommunicable illnesses led to 43 million deaths in 2021. This rise in chronic illnesses is driving the endoscopy devices market demand.
Progressions in endoscopy devices play an important part in accuracy, safety, and practicability of the devices. Inventions such as high-definition imaging, flexible endoscopes, and robotic-assisted have augmented the gamut of clinical applications for endoscopy, enabling more precise diagnostics and minimally invasive surgeries.
Endoscopy Devices Market Report Highlights
• In terms of devices type, the endoscopes segment held the largest market share in 2024, given their essential role in diagnostic and therapeutic procedures across medical specialties.
• Based on end-use, the hospital sector is anticipated to expand significantly due to its advanced infrastructure and capacity to support complex endoscopic procedures.
• North America led in market revenue share in 2024, attributed to its robust healthcare systems and early adoption of innovative endoscopic technologies.
The Asia Pacific market is expected to grow the fastest, fueled by improving healthcare access and increasing investments in medical infrastructure. Major players have adopted strategies such as product instigation, agreement, product consent, and augmentation to improve their product portfolio.
Major companies are:
• Arthrex, Inc.
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Cook Medical
• Fujifilm Holdings Corporation
• Hoya Corporation
• Johnson & Johnson
• KARL STORZ SE & Co. KG
• Medtronic plc
• Olympus Corporation
• PENTAX Medical
• Richard Wolf GmbH
• Shanghai Aohua Photoelectricity Endoscope Co., Ltd.
• STERIS
• Stryker Corporation
North America dominated the endoscopy devices market in 2024 due to the region’s excessively advanced healthcare framework and early adoption of progressive medical technologies. Asia Pacific is projected to witness the fastest growth due to enhancing the healthcare framework and growing healthcare disbursement covering emerging economies.
